Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Cyclin E overexpression sensitizes triple negative breast cancer to Wee1 kinase Inhibition.

Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JP, Bui T, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, Meric-Bernstam F, Hunt KK, Keyomarsi K.

Clin Cancer Res. 2018 Sep 4. pii: clincanres.1446.2018. doi: 10.1158/1078-0432.CCR-18-1446. [Epub ahead of print]

PMID:
30181387
2.

Venous thromboembolism, factor VIII and chronic kidney disease.

Cheung KL, Bouchard BA, Cushman M.

Thromb Res. 2018 Jul 31;170:10-19. doi: 10.1016/j.thromres.2018.07.029. [Epub ahead of print] Review.

PMID:
30081388
3.

Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.

Ren C, Zhang G, Han F, Fu S, Cao Y, Zhang F, Zhang Q, Meslamani J, Xu Y, Ji D, Cao L, Zhou Q, Cheung KL, Sharma R, Babault N, Yi Z, Zhang W, Walsh MJ, Zeng L, Zhou MM.

Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):7949-7954. doi: 10.1073/pnas.1720000115. Epub 2018 Jul 16.

PMID:
30012592
4.

Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.

Cheung KL, Zakai NA, Callas PW, Howard G, Mahmoodi BK, Peralta CA, Judd SE, Kurella Tamura M, Cushman M.

J Thromb Haemost. 2018 Sep;16(9):1743-1752. doi: 10.1111/jth.14235. Epub 2018 Aug 9.

PMID:
29984467
5.

Treatment strategies and survival outcomes in older women with breast cancer: A comparative study between the FOCUS cohort and Nottingham cohort.

Schuil H, Derks M, Liefers GJ, Portielje J, van de Velde C, Syed B, Green A, Ellis I, Cheung KL, Bastiaannet E.

J Geriatr Oncol. 2018 May 18. pii: S1879-4068(17)30286-2. doi: 10.1016/j.jgo.2018.05.004. [Epub ahead of print]

6.

Fulvestrant for the treatment of advanced breast cancer.

Blackburn SA, Parks RM, Cheung KL.

Expert Rev Anticancer Ther. 2018 Jul;18(7):619-628. doi: 10.1080/14737140.2018.1473038. Epub 2018 May 15.

PMID:
29749272
7.

Optimising endocrine therapy in postmenopausal women with advanced breast cancer.

Yau THL, Cheung KL.

Endocr Relat Cancer. 2018 Jul;25(7):705-721. doi: 10.1530/ERC-18-0021. Epub 2018 Apr 19.

PMID:
29674428
8.

Effect of a financial incentive on the acceptance of a smoking cessation programme with service charge: a cluster-controlled trial.

Wong KS, Fu SN, Cheung KL, Dao MC, Sy WM.

Hong Kong Med J. 2018 Apr;24(2):128-136. doi: 10.12809/hkmj176960. Epub 2018 Apr 4.

9.

Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer.

Robertson JFR, Cheung KL, Noguchi S, Shao Z, Degboe A, Lichfield J, Thirlwell J, Fazal M, Ellis MJ.

Eur J Cancer. 2018 May;94:206-215. doi: 10.1016/j.ejca.2018.02.026. Epub 2018 Mar 22.

10.

Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.

Trapero-Bertran M, Muñoz C, Coyle K, Coyle D, Lester-George A, Leidl R, Németh B, Cheung KL, Pokhrel S, Lopez-Nicolás Á.

Addiction. 2018 Jun;113 Suppl 1:65-75. doi: 10.1111/add.14090. Epub 2018 Mar 13.

11.

Estimates of costs for modelling return on investment from smoking cessation interventions.

Trapero-Bertran M, Leidl R, Muñoz C, Kulchaitanaroaj P, Coyle K, Präger M, Józwiak-Hagymásy J, Cheung KL, Hiligsmann M, Pokhrel S; EQUIPT Study Group.

Addiction. 2018 Jun;113 Suppl 1:32-41. doi: 10.1111/add.14091. Epub 2018 Mar 13.

12.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer.

Lei YY, Ho SC, Cheng A, Kwok C, Lee CI, Cheung KL, Lee R, Loong HHF, He YQ, Yeo W.

J Natl Compr Canc Netw. 2018 Mar;16(3):275-285. doi: 10.6004/jnccn.2017.7202.

PMID:
29523666
13.

Relevance of barriers and facilitators in the use of health technology assessment in Colombia.

Dams F, Gonzalez Rodriguez JL, Cheung KL, Wijnen BFM, Hiligsmann M.

J Med Econ. 2018 May;21(5):510-517. doi: 10.1080/13696998.2018.1449751. Epub 2018 Mar 23.

PMID:
29513062
14.

OPTIMIZING USABILITY OF AN ECONOMIC DECISION SUPPORT TOOL: PROTOTYPE OF THE EQUIPT TOOL.

Cheung KL, Hiligsmann M, Präger M, Jones T, Józwiak-Hagymásy J, Muñoz C, Lester-George A, Pokhrel S, López-Nicolás Á, Trapero-Bertran M, Evers SMAA, de Vries H.

Int J Technol Assess Health Care. 2018 Jan;34(1):68-77. doi: 10.1017/S0266462317004470. Epub 2018 Feb 19.

PMID:
29455684
15.

Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study.

Kulchaitanaroaj P, Kaló Z, West R, Cheung KL, Evers S, Vokó Z, Hiligsmann M, de Vries H, Owen L, Trapero-Bertran M, Leidl R, Pokhrel S.

BMC Health Serv Res. 2018 Feb 14;18(1):115. doi: 10.1186/s12913-018-2923-2.

16.

Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.

Anraad C, Cheung KL, Hiligsmann M, Coyle K, Coyle D, Owen L, West R, de Vries H, Evers SM, Pokhrel S.

Addiction. 2018 Jun;113 Suppl 1:96-105. doi: 10.1111/add.14093. Epub 2018 Feb 11.

17.

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer.

Gong C, Man EPS, Tsoi H, Lee TKW, Lee P, Ma ST, Wong LS, Luk MY, Rakha EA, Green AR, Ellis IO, Lam EW, Cheung KL, Khoo US.

Clin Cancer Res. 2018 Aug 1;24(15):3681-3691. doi: 10.1158/1078-0432.CCR-17-2259. Epub 2018 Feb 2.

PMID:
29420220
18.

Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.

Syed BM, Morgan D, Setty T, Green AR, Paish EC, Ellis IO, Cheung KL.

PLoS One. 2018 Jan 25;13(1):e0191979. doi: 10.1371/journal.pone.0191979. eCollection 2018.

19.

Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.

Németh B, Józwiak-Hagymásy J, Kovács G, Kovács A, Demjén T, Huber MB, Cheung KL, Coyle K, Lester-George A, Pokhrel S, Vokó Z.

Addiction. 2018 Jun;113 Suppl 1:76-86. doi: 10.1111/add.14089. Epub 2018 Jan 25.

20.

Most important barriers and facilitators of HTA usage in decision-making in Europe.

Cheung KL, Evers SMAA, De Vries H, Levy P, Pokhrel S, Jones T, Danner M, Wentlandt J, Knufinke L, Mayer S, Hiligsmann M.

Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):297-304. doi: 10.1080/14737167.2018.1421459. Epub 2018 Jan 5.

PMID:
29303374
21.

Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.

Syed BM, Morgan D, Setty T, Green AR, Paish EC, Ellis IO, Cheung KL.

PLoS One. 2017 Dec 28;12(12):e0188528. doi: 10.1371/journal.pone.0188528. eCollection 2017. Erratum in: PLoS One. 2018 Jan 25;13(1):e0191979.

22.

Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.

Cheung KL, Wijnen BFM, Hiligsmann M, Coyle K, Coyle D, Pokhrel S, de Vries H, Präger M, Evers SMAA.

Addiction. 2018 Jun;113 Suppl 1:87-95. doi: 10.1111/add.14069. Epub 2017 Dec 15.

23.

Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.

Huber MB, Präger M, Coyle K, Coyle D, Lester-George A, Trapero-Bertran M, Nemeth B, Cheung KL, Stark R, Vogl M, Pokhrel S, Leidl R.

Addiction. 2018 Jun;113 Suppl 1:52-64. doi: 10.1111/add.14062. Epub 2017 Dec 15.

24.

Exploring consensus on how to measure smoking cessation. A Delphi study.

Cheung KL, de Ruijter D, Hiligsmann M, Elfeddali I, Hoving C, Evers SMAA, de Vries H.

BMC Public Health. 2017 Nov 21;17(1):890. doi: 10.1186/s12889-017-4902-7. Review.

25.

Tumour boards in geriatric oncology.

Wildes TM, O'Donovan A, Colloca GF, Cheung KL.

Age Ageing. 2018 Mar 1;47(2):168-170. doi: 10.1093/ageing/afx171.

PMID:
29145553
26.

Effectiveness of a Video-Versus Text-Based Computer-Tailored Intervention for Obesity Prevention after One Year: A Randomized Controlled Trial.

Cheung KL, Schwabe I, Walthouwer MJL, Oenema A, Lechner L, de Vries H.

Int J Environ Res Public Health. 2017 Oct 23;14(10). pii: E1275. doi: 10.3390/ijerph14101275.

27.

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.

Ali EE, Cheung KL, Lee CP, Leow JL, Yap KY, Chew L.

Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):283-289. doi: 10.4103/2347-5625.212864.

28.

Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors.

Verhoef D, Visscher KM, Vosmeer CR, Cheung KL, Reitsma PH, Geerke DP, Bos MHA.

Nat Commun. 2017 Sep 13;8(1):528. doi: 10.1038/s41467-017-00647-9.

29.

Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.

Feig C, Cheung KL, Hiligsmann M, Evers SMAA, Simon J, Mayer S.

Expert Rev Pharmacoecon Outcomes Res. 2018 Apr;18(2):223-232. doi: 10.1080/14737167.2017.1375407. Epub 2017 Sep 8.

PMID:
28862060
30.

MOST IMPORTANT BARRIERS AND FACILITATORS REGARDING THE USE OF HEALTH TECHNOLOGY ASSESSMENT.

Cheung KL, Evers SMAA, de Vries H, Hiligsmann M.

Int J Technol Assess Health Care. 2017 Jan;33(2):183-191. doi: 10.1017/S0266462317000290.

PMID:
28849758
31.

Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial.

Collins K, Reed M, Lifford K, Burton M, Edwards A, Ring A, Brain K, Harder H, Robinson T, Cheung KL, Morgan J, Audisio R, Ward S, Richards P, Martin C, Chater T, Pemberton K, Nettleship A, Murray C, Walters S, Bortolami O, Armitage F, Leonard R, Gath J, Revell D, Green T, Wyld L.

BMJ Open. 2017 Jul 31;7(7):e015133. doi: 10.1136/bmjopen-2016-015133.

32.
33.

Controversial issues in the management of older adults with early breast cancer.

Mislang AR, Cheung KL, Hamaker ME, Kunkler I, Markopoulos C, Orecchia R, Brain E, Biganzoli L.

J Geriatr Oncol. 2017 Nov;8(6):397-402. doi: 10.1016/j.jgo.2017.05.004. Epub 2017 Jun 9. Review.

PMID:
28602710
34.

The impact of non-response bias due to sampling in public health studies: A comparison of voluntary versus mandatory recruitment in a Dutch national survey on adolescent health.

Cheung KL, Ten Klooster PM, Smit C, de Vries H, Pieterse ME.

BMC Public Health. 2017 Mar 23;17(1):276. doi: 10.1186/s12889-017-4189-8.

35.

Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.

Parks RM, Cheung KL.

Breast. 2017 Jun;33:57-70. doi: 10.1016/j.breast.2017.02.019. Epub 2017 Mar 8. Review.

PMID:
28282588
36.

Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.

Cheung KL, Zhang F, Jaganathan A, Sharma R, Zhang Q, Konuma T, Shen T, Lee JY, Ren C, Chen CH, Lu G, Olson MR, Zhang W, Kaplan MH, Littman DR, Walsh MJ, Xiong H, Zeng L, Zhou MM.

Mol Cell. 2017 Mar 16;65(6):1068-1080.e5. doi: 10.1016/j.molcel.2016.12.022. Epub 2017 Mar 3.

37.

What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment.

Morgan JL, Walters SJ, Collins K, Robinson TG, Cheung KL, Audisio R, Reed MW, Wyld L.

Eur J Surg Oncol. 2017 Jul;43(7):1282-1287. doi: 10.1016/j.ejso.2017.01.012. Epub 2017 Feb 2.

38.

Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Cheung KL, Zakai NA, Folsom AR, Kurella Tamura M, Peralta CA, Judd SE, Callas PW, Cushman M.

Am J Kidney Dis. 2017 Aug;70(2):182-190. doi: 10.1053/j.ajkd.2016.10.039. Epub 2017 Jan 23.

39.

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.

Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi K.

Oncotarget. 2017 Feb 28;8(9):14897-14911. doi: 10.18632/oncotarget.14689.

40.

Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.

Berg ML, Cheung KL, Hiligsmann M, Evers S, de Kinderen RJA, Kulchaitanaroaj P, Pokhrel S.

Addiction. 2017 Jun;112(6):946-967. doi: 10.1111/add.13748. Epub 2017 Feb 15. Review.

41.

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.

Robertson JFR, Bondarenko IM, Trishkina E, Dvorkin M, Panasci L, Manikhas A, Shparyk Y, Cardona-Huerta S, Cheung KL, Philco-Salas MJ, Ruiz-Borrego M, Shao Z, Noguchi S, Rowbottom J, Stuart M, Grinsted LM, Fazal M, Ellis MJ.

Lancet. 2016 Dec 17;388(10063):2997-3005. doi: 10.1016/S0140-6736(16)32389-3. Epub 2016 Nov 29.

PMID:
27908454
42.

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.

Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K.

Clin Cancer Res. 2017 Jun 15;23(12):2991-3002. doi: 10.1158/1078-0432.CCR-16-2217. Epub 2016 Nov 23.

43.

Mortality, length of stay, bloodstream and respiratory viral infections in a pediatric intensive care unit.

Hon KL, Luk MP, Fung WM, Li CY, Yeung HL, Liu PK, Li S, Tsang KY, Li CK, Chan PK, Cheung KL, Leung TF, Koh PL.

J Crit Care. 2017 Apr;38:57-61. doi: 10.1016/j.jcrc.2016.09.019. Epub 2016 Sep 30.

PMID:
27863269
44.

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a.

Cheung KL, Jarrett R, Subramaniam S, Salimi M, Gutowska-Owsiak D, Chen YL, Hardman C, Xue L, Cerundolo V, Ogg G.

J Exp Med. 2016 Oct 17;213(11):2399-2412. Epub 2016 Sep 26.

45.

Using Best-Worst Scaling to Investigate Preferences in Health Care.

Cheung KL, Wijnen BF, Hollin IL, Janssen EM, Bridges JF, Evers SM, Hiligsmann M.

Pharmacoeconomics. 2016 Dec;34(12):1195-1209. Review.

46.

Alcohol Exposure in Breastfed Neonates Associated with Chinese Chicken Wine.

Hon KL, Wong YCT, Chau IK, Chau MK, Cheung KL, Wong W.

Indian J Pediatr. 2016 Nov;83(12-13):1495-1496. doi: 10.1007/s12098-016-2181-4. Epub 2016 Jun 28. No abstract available.

PMID:
27349563
47.

Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.

Vokó Z, Cheung KL, Józwiak-Hagymásy J, Wolfenstetter S, Jones T, Muñoz C, Evers SM, Hiligsmann M, de Vries H, Pokhrel S; EQUIPT Study Group.

Health Res Policy Syst. 2016 May 26;14(1):38. doi: 10.1186/s12961-016-0110-7.

48.

Renal Palliative Care Studies: Coming of Age.

Cheung KL, Periyakoil VS.

J Palliat Med. 2016 Jun;19(6):582-3. doi: 10.1089/jpm.2016.0175. Epub 2016 May 16. No abstract available.

PMID:
27183468
49.

Perturbational Blowup Solutions to the Two-Component Dullin-Gottwald-Holm System.

Cheung KL.

ScientificWorldJournal. 2016;2016:5632798. doi: 10.1155/2016/5632798. Epub 2016 Mar 31.

50.

Blowup Phenomenon of Solutions for the IBVP of the Compressible Euler Equations in Spherical Symmetry.

Cheung KL, Wong S.

ScientificWorldJournal. 2016;2016:3781760. doi: 10.1155/2016/3781760. Epub 2016 Feb 3.

Supplemental Content

Loading ...
Support Center